Concurrent Session VI - CHALLENGES IN IBD
Moderators: Ashish Patel, MD, UT Southwestern Medical Center and Jenifer Strople, MD, Ann & Robert H Lurie Children’s Hospital

“Fail first” and other payor driven policies: How can physicians become effective advocates?
Sandra Kim, MD, Children's Hospital of Pittsburgh of UPMC
Objectives:
  • Summarize the impact of IBD care costs in the United States
  • Provide an overview on different issues impacting care access (“fail first” components of step therapy, lack of coverage for medical foods, and opt out plans) for patients with IBD
  • Discuss ongoing bills that have been proposed to improve access to care
Sandra Kim
(Adobe PDF File)
Treatment of intestinal inflammation in a murine model with epicutaneous tolerance induction requires TGF-B and IL-10 but not FOXP3+ Tregs David Dunkin
David Dunkin
(Adobe PDF File)
Role of small molecules in the treatment of inflammatory bowel disease
Jeffrey Hyams, MD, Connecticut Children's Medical Center
Objectives:
  • Understand the mechanisms of action and pharmacology of emerging small molecule therapies
  • Understand the potential role of available and emerging small molecules in the treatment of pediatric IBD
Jeffrey Hyams
(Adobe PDF File)
Characterization of the fistula-associated microbiome in pediatric perianal Crohn’s disease Jessica Breton
Jessica Breton
(Adobe PDF File)